New Sleeping Sickness Drug Gets Green Light
Fexinidazole is a new drug for the treatment of Human African Trypanosomiasis commonly known as sleeping sickness. It is the first all-oral treatment for the disease which is transmitted by the bite of a tsetse fly, and has been approved by the European Medicines Agency.
And Now, a New Drug for Sleeping Sickness
East African, 28 November 2018
Scientists working on Neglected Tropical Diseases have welcomed the approval of a new drug for the treatment of Human African Trypanosomiasis, commonly known as sleeping sickness. Read more »
Tsetse fly (file photo).